Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Chief Financial Officer | June 04, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date June 04, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,850 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Sale · Disposed 169,427 · Balance 109,850 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2021 Filed Oct 15, 2021 22:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 49,918 | $7.80 | $389,360.40 |
DisclosureSEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. Read SEC document |
| July 16, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 20,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · derivative · entry 8 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,334 Underlying: Common Stock · 20,000 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Options vested on the 18th of each month for 48 months beginning on January 18, 2015. Read SEC document |
| July 16, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 20,000 | $4.80 | $96,000.00 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · nonDerivative · entry 6 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 50,000 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · derivative · entry 7 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,918 Underlying: Common Stock · 50,000 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F6 · derivative.exercise_date: Options vested on the 28th of each month for 48 months beginning on July 28, 2013. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 7,965 | $55.59 | $442,777.54 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · nonDerivative · entry 5 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,417 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.35 to $56.075, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 12,554 | $54.79 | $687,772.15 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · nonDerivative · entry 4 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,382 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.35 to $55.34, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 16,746 | $53.70 | $899,325.51 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · nonDerivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,936 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.34 to $54.32, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 12,735 | $52.73 | $671,478.35 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,682 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.34 to $53.33, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 50,000 | $3.24 | $162,000.00 |
DisclosureSEC source: 0001104659-21-093183 · tm2122488-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 10,417 | $0.00 Strike: $10.32 | $0.00 |
DisclosureSEC source: 0001104659-21-075822 · tm2118280d1_4.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,417 shares Expires 2021-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested in equal installments every 6 months for 48 months beginning December 20, 2011. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 10,417 | $10.32 | $107,503.44 |
DisclosureSEC source: 0001104659-21-075822 · tm2118280d1_4.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:09 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantRestricted Stock Rights · Derivative | 10,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-035160 · tm219529d3_4seq1.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,667 Underlying: Common Stock · 10,667 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. F3 · derivative.expiration_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:09 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 21,333 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-21-035160 · tm219529d3_4seq1.xml · derivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,333 Underlying: Common Stock · 21,333 shares Expires 2028-03-09 F1 · derivative.exercise_date: 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 21:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 100,000 | $0.00 Strike: $16.93 | $0.00 |
DisclosureSEC source: 0001104659-20-041951 · tm2014753d4_form4.xml · derivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-03-30 F1 · derivative.exercise_date: 1/48 of options vest on the 30th of each month for forty-eight months beginning 4/30/2020. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 21,872 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-19-066744 · tm1923757d1_form4.xml · derivative · entry 6 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,164 Underlying: Common Stock · 21,872 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 177,200 shares, became exercisable in 48 equal monthly installments on the 19th of each month beginning on August 19, 2015. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 21,872 | $14.65 | $320,505.73 |
DisclosureSEC source: 0001104659-19-066744 · tm1923757d1_form4.xml · nonDerivative · entry 4 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 21,872 | $3.07 | $67,147.04 |
DisclosureSEC source: 0001104659-19-066744 · tm1923757d1_form4.xml · nonDerivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 113,164 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-19-066744 · tm1923757d1_form4.xml · derivative · entry 5 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,036 Underlying: Common Stock · 113,164 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 177,200 shares, became exercisable in 48 equal monthly installments on the 19th of each month beginning on August 19, 2015. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 113,164 | $14.85 | $1,680,168.54 |
DisclosureSEC source: 0001104659-19-066744 · tm1923757d1_form4.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 113,164 | $3.07 | $347,413.48 |
DisclosureSEC source: 0001104659-19-066744 · tm1923757d1_form4.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 10:04 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 90,000 | $0.00 Strike: $12.79 | $0.00 |
DisclosureSEC source: 0001144204-19-018102 · tv518162_4.xml · derivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-04-01 F1 · derivative.exercise_date: 1/48 of options vest on the 1st of each month for forty-eight months beginning 4/01/2019. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 18:12 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to Purchase Common Stock · Derivative | 66,300 | $0.00 Strike: $8.65 | $0.00 |
DisclosureSEC source: 0001144204-18-018218 · tv489933_4.xml · derivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,300 Underlying: Common Stock · 66,300 shares Expires 2028-03-28 F1 · derivative.exercise_date: 1/48 of the options vest on the 28th of each month for forty-eight months beginning on March 28, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to Purchase Common Stock · Derivative | 81,000 | $3.21 Strike: $3.21 | $260,010.00 |
DisclosureSEC source: 0001144204-17-028956 · v467641_4.xml · derivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 81,000 shares Expires 2027-05-18 F1 · derivative.exercise_date: 1/48 of the options vest on the 18th of each month for forty-eight months beginning on 5/18/2017; provided that up to 1/2 of the options may accelerate based on achievement of certain performance goals. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.